Skip to content

Trevo 90238Recalls & reported problems

Stryker Corporation · Trevo Pro 18 Microcatheter · Class 2

2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
5
Deaths reported
0
Injuries reported
1
Recalls naming it
2

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00815742002386), received between Feb 19, 2019 and Aug 14, 2024 — classified as 1 injury, 4 malfunctions.

The most frequently reported specific device problem is “Peeled/Delaminated” (2 reports).

2 FDA recall records name this device's identifier, 2 still open.

4 other recalls cover devices cleared under the same FDA submission (K113260); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Apr 23, 2024Open, Classified

    Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.

    Z-1904-2024 · Root cause: Process design · FDA record ↗

  2. Dec 6, 2023Open, Classified

    The microcatheter IFU contains an intended use that has not been evaluated by the FDA.

    Z-1084-2024 · Root cause: Under Investigation by firm · FDA record ↗

Most reported problems

Device problems

  • Peeled/Delaminated2
  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Fracture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • No Consequences Or Impact To Patient1
  • Perforation of Vessels1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 14, 2024Peeled/Delaminated; Peeled/Delaminated

    DURING RIGHT INTERNAL CAROTID ARTERY (ICA) THROMBECTOMY PROCEDURE, THE OPERATOR FLUSHED AND DELIVERED A GUIDEWIRE INTO A SUBJECT MICROCATHETER AND DELIVERED THEM TO THE TARGET LESION. AFTER THE SUBJECT MICROCATHETER REACHED MCA M1, THE OPERATOR DEPLOYED A RETRIEVER AND ASPIRATED WITH A DISTAL ACCESS CATHETER AT SIPHON SECTION. NEXT, THE OPERATOR WITHDREW THE RETRIEVER AND THE SUBJECT MICROCATHETER BACK INTO THE DISTAL ACCESS CATHETER AND CHECKED ICA C7 UNDER THE DIGITAL SUBTRACTION ANGIOGRAPHY (DSA). THE ANGIOGRAPHY REVEALED THAT THE C7 WAS NOT OPENED. THE OPERATOR PREPARED TO PERFORM THE SECOND THROMBECTOMY. WHEN THE OPERATOR DELIVERED THE GUIDEWIRE INTO THE SUBJECT MICROCATHETER, HE FELT FRICTION AND RESISTANCE. WHEN THE OPERATOR REACHED M1, HE DELIVERED THE RETRIEVER AND IT ALSO ENCOUNTERED RESISTANCE INSIDE THE SUBJECT MICROCATHETER. THUS, THE OPERATOR WITHDREW THE RETRIEVER AND THE DISTAL ACCESS CATHETER AND REPLACED THE SUBJECT MICROCATHETER. THE OPERATOR CONCLUDED THAT THE COATING OF THE SUBJECT MICROCATHETER PEELED OFF WHICH CAUSED THE RESISTANCE. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19986746 ↗
  • MalfunctionMar 26, 2024Peeled/Delaminated; Peeled/Delaminated

    IT WAS REPORTED THAT DURING A NEUROVASCULAR PROCEDURE WHEN THE OPERATOR ATTEMPTED TO DELIVER THE RETRIEVER STENT THROUGH THE SUBJECT MICROCATHETER, THE STENT RETRIEVER COULD NOT BE ADVANCED PAST MIDDLE CEREBRAL ARTERY (MCA) C5 SEGMENT. THE OPERATOR WITHDREW THE SUBJECT MICROCATHETER AND THE STENT OUT TOGETHER TO CHECK AND FOUND THAT THE INNER WALL PTFE LINER OF THE SUBJECT MICROCATHETER WAS PEELED. THE SUBJECT MICROCATHETER WAS REPLACED AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18984012 ↗
  • MalfunctionNov 30, 2022Fracture; Fracture

    IT WAS REPORTED THAT DURING AN ACUTE THROMBECTOMY CASE, WHEN THE PHYSICIAN ATTEMPTED TO BUILD ACCESS WITH THE SUPPORT OF A GUIDEWIRE, THE DISTAL OF THE SUBJECT CATHETER KINKED AND EVENTUALLY FRACTURED WHILE BEING DELIVERED INTO THE PATIENT. THE DEVICE WAS REMOVED WITH THE GUIDEWIRE AND REPLACED. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH NO CLINICAL CONSEQUENCES TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15886476 ↗
  • InjuryJan 6, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DURING THROMBECTOMY PROCEDURE, THE SUBJECT DEVICE MICROCATHETER (TREVO PRO MICROCATHETER) AND OTHER DEVICES WERE USED TO REMOVE THE PROXIMAL FACE OF CLOT LOCATED AT THE RIGHT ICA (INTERNAL CAROTID ARTERY)- INTRACRANIAL-T (BIFURCATION) EXTENDING TO M1 AND M2. PRIOR PROCEDURE, THE PATIENT NEUROLOGICAL ASSESSMENT SHOWED THE TICI (THROMBOLYSIS IN CEREBRAL INFARCTION SCORE) OF 0. IT WAS REPORTED THAT THE VESSEL PERFORATION OCCURRED DURING MANIPULATION. THERE WERE NO SYMPTOMATIC INTRACRANIAL HEMORRHAGE (SICH) OR NEUROLOGICAL DETERIORATION REPORTED. THE EVENT WAS RESOLVED WITHOUT MEDICAL TREATMENT TO THE PATIENT. 24 HOURS POST PROCEDURE, THE PATIENT NEUROLOGICAL ASSESSMENT SHOWED (TICI) OF 3 AND NIHSS OF 18. ACCORDING TO THE SITE, THE RELATIONSHIP OF THE VESSEL PERFORATION TO THE SUBJECT DEVICE MICROCATHETER AND TO THE PROCEDURE. NO OTHER INFORMATION WAS PROVIDED.

    Patient problems: Perforation of Vessels

    MAUDE report 11121898 ↗
  • MalfunctionFeb 19, 2019Break; Break

    ANALYSIS OF THE RETURNED DEVICE NOTED THAT THE MICROCATHETER SHAFT WAS BROKEN. NO CONSEQUENCES TO THE PATIENT WERE REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8352625 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K113260. One submission often covers many models, so check the product and lot details in each record.

  • Z-0347-2018 · Nov 28, 2017 · Terminated
    Trevo XP ProVue System kit containing 1) Trevo XP ProVue Retriever, 4x20mm and 2) Trevo Pro18 Microcatheter
  • Z-0277-2018 · Nov 3, 2017 · Terminated
    Trevo(TM) XP ProVue Procedure Pack, TREVO(TM) XP PROVUE RETRIEVER, 6 mm, 25 mm, .Excelsior(TM) XT-27(TM) 1 TIP STRAIGHT, 150 cm, 6 cm, Microcatheter; UPN 93068 Stroke intervention
  • Z-0275-2018 · Nov 3, 2017 · Terminated
    Stroke Fast Pack(TM), Trevo(TM) XP, TREVO(TM) XP PROVUE RETRIEVER, 6 mm, 25 mm; Excelsior(TM) XT-27(tm), MICROCATHETER,150 cm, 6 cm; AXS Catalyst(TM) 6, Distal Access Catheter, 0.0
  • Z-0276-2018 · Nov 3, 2017 · Terminated
    Stroke Fast Pack(TM), Trevo(TM) XP, TREVO(TM) XP PROVUE RETRIEVER, 4 mm, 20 mm, ; Trevo(TM) Pro 18, TREVO PRO 18 MICROCATHETER, 0.021 in ID, 150 cm; AXS Catalyst(TM) 6, Distal Acc

Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices

All CATHETER, INTRAVASCULAR, DIAGNOSTIC devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.